Sai Life Sciences Limited annual operating income for fiscal 2026 was ₹4.7 billion, an increase of 71.1% from ₹2.7 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Operating Income (EBIT) | ₹4.7B | ₹2.7B | ₹1.8B | ₹768M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ₹1.0B | ₹1.3B | ₹1.4B | ₹832M | ₹1.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More SAILIFE metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow
All SAILIFE financial statements → Interactive SAILIFE charts →
About TickerBase · Data methodology & sources · Privacy · Terms